Medical Net, Inc. (TYO:3645)
Japan · Delayed Price · Currency is JPY 230.00
-2.00 (-0.86%)
Nov 2, 2026, 3:30 PM JST
Medical Net Income Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 6,725 | 6,732 | 6,077 | 5,252 | 4,500 | 3,745 | |
Revenue Growth | 7.09% | 10.78% | 15.71% | 16.71% | 20.16% | 12.46% |
Cost of Revenue | 4,806 | 4,736 | 4,112 | 3,411 | 2,720 | 2,285 |
Gross Profit | 1,919 | 1,996 | 1,965 | 1,841 | 1,780 | 1,460 |
Selling, General & Admin | 1,774 | 1,804 | 1,864 | 1,524 | 1,396 | 1,000 |
Operating Expenses | 1,774 | 1,804 | 1,866 | 1,542 | 1,401 | 1,010 |
Operating Income | 145 | 192 | 99 | 299 | 379 | 450 |
Interest Expense | -17 | -15 | -11 | -6 | -3 | -1 |
Interest & Investment Income | 8 | 7 | 3 | 1 | - | - |
Currency Exchange Gain (Loss) | 52 | 84 | 25 | 34 | 45 | 8 |
Other Non Operating Income (Expenses) | -7 | - | 18 | -7 | 10 | -5 |
EBT Excluding Unusual Items | 181 | 268 | 134 | 321 | 431 | 452 |
Gain (Loss) on Sale of Investments | - | - | 352 | -4 | -40 | 84 |
Gain (Loss) on Sale of Assets | 1 | 1 | - | 5 | 2 | - |
Asset Writedown | -9 | -10 | -154 | -170 | -143 | - |
Other Unusual Items | -1 | -1 | -308 | -1 | - | - |
Pretax Income | 172 | 258 | 24 | 151 | 250 | 536 |
Income Tax Expense | 76 | 96 | 62 | 126 | 141 | 137 |
Earnings From Continuing Operations | 96 | 162 | -38 | 25 | 109 | 399 |
Minority Interest in Earnings | -22 | -25 | -30 | -20 | 7 | -15 |
Net Income | 74 | 137 | -68 | 5 | 116 | 384 |
Net Income to Common | 74 | 137 | -68 | 5 | 116 | 384 |
Net Income Growth | - | - | - | -95.69% | -69.79% | 197.67% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Change | 3.69% | 2.97% | -1.34% | 0.94% | 2.40% | 3.65% |
EPS (Basic) | 8.01 | 14.91 | -7.62 | 0.55 | 12.95 | 43.88 |
EPS (Diluted) | 8.01 | 14.91 | -7.62 | 0.55 | 12.95 | 43.88 |
EPS Growth | - | - | - | -95.73% | -70.50% | 187.19% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | - | 90 | -211 | 87 | 410 | 340 |
Free Cash Flow Per Share | - | 9.79 | -23.64 | 9.62 | 45.76 | 38.85 |
Dividend Per Share | 3.000 | 3.000 | 3.000 | 3.000 | 2.500 | 2.500 |
Dividend Growth | 0% | 0% | 0% | 20.00% | 0% | 0% |
Gross Margin | 28.54% | 29.65% | 32.34% | 35.05% | 39.56% | 38.98% |
Operating Margin | 2.16% | 2.85% | 1.63% | 5.69% | 8.42% | 12.02% |
Profit Margin | 1.10% | 2.04% | -1.12% | 0.10% | 2.58% | 10.25% |
Free Cash Flow Margin | - | 1.34% | -3.47% | 1.66% | 9.11% | 9.08% |
EBITDA | 222.25 | 269 | 175 | 352 | 440 | 479 |
EBITDA Margin | 3.31% | 4.00% | 2.88% | 6.70% | 9.78% | 12.79% |
D&A For EBITDA | 77.25 | 77 | 76 | 53 | 61 | 29 |
EBIT | 145 | 192 | 99 | 299 | 379 | 450 |
EBIT Margin | 2.16% | 2.85% | 1.63% | 5.69% | 8.42% | 12.02% |
Effective Tax Rate | 44.19% | 37.21% | 258.33% | 83.44% | 56.40% | 25.56% |
Advertising Expenses | - | 116 | 154 | 119 | 119 | 108 |